Page last updated: 2024-10-22

aminoglutethimide and Psychotic Disorders

aminoglutethimide has been researched along with Psychotic Disorders in 2 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ghadirian, AM1
Engelsmann, F1
Dhar, V1
Filipini, D1
Keller, R1
Chouinard, G1
Murphy, BE1
Barnett, IG1
Nabarro, JD1
LeQuesne, LP1

Other Studies

2 other studies available for aminoglutethimide and Psychotic Disorders

ArticleYear
The psychotropic effects of inhibitors of steroid biosynthesis in depressed patients refractory to treatment.
    Biological psychiatry, 1995, Mar-15, Volume: 37, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aminoglutethimide; Bipolar Disorder; Depressive Disorder; Dose-Respo

1995
Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.
    Proceedings of the Royal Society of Medicine, 1970, Volume: 63, Issue:4

    Topics: Adrenalectomy; Adult; Aminoglutethimide; Aniline Compounds; Anticonvulsants; Cushing Syndrome; Femal

1970